Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-021637

Options or other derivatives

  • Director acquired 56,131 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Miller-Rich Nancy Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +53,812 53,812 D
Miller-Rich Nancy Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +2,319 2,319 D
Loading xslF345X03/doc4.xml…